- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
High fasting blood sugar in diabetics increases risk of developing TB: JAMA
Long-standing diabetes mellitus (DM) associated with the development of tuberculosis (TB), suggests a recent study published in the JAMA Network Open.
It was shown that longer duration of diabetes was associated with the development of TB, showing a dose-response association. TB was more common among participants with Fasting blood sugar levels greater than or equal to 202 mg/dL. These findings suggest that for TB prevention, fasting blood sugar control should be reinforced even in patients with new-onset diabetes.
A group of researchers from Korea conducted a study to evaluate the association of diabetes status with the development of TB in the general population.
This population-based cohort study used data from the Korean National Health Insurance System database. Adult participants without a history of TB who underwent a health screening in 2009 were included. Eligible participants were followed up for incident TB cases from 1 year after the day of health screening until December 31, 2018. Data analysis was performed from September 2019 to September 2020.
Five levels of diabetes status were evaluated: normal glucose, impaired fasting blood sugar (considered as without diabetes), new-onset diabetes, diabetes duration less than 5 years, and diabetes duration 5 years or longer (considered as having diabetes).
The primary outcome was newly diagnosed tuberculosis.
The results of the study are as follows:
Among 4 423 177 participants, the mean (SD) age was 46.5 (13.9) years, and there were 2 597 142 men (58.7%).
A total of 26 458 participants (0.6%) received a diagnosis of TB within a median (interquartile range) of 8.3 (8.1-8.6) years of follow-up.
· An increased risk of TB was observed in participants with diabetes compared with those without diabetes.
· Although participants with impaired fasting glucose did not show an increased risk of TB incidence, the risk of TB incidence increased with diabetes duration.
· Among participants with new-onset diabetes, compared with those in the lowest decile the risk of TB was significantly increased for those in the highest decile.
Thus, the researchers concluded that these findings suggest that longer diabetes duration is associated with the development of TB, showing a dose-response association. Among participants with new-onset diabetes, incident TB was more common among those with Fasting blood sugar levels greater than or equal to 202 mg/dL.
Reference:
Diabetes Status and Association with Risk of Tuberculosis Among Korean Adults by Yoo J et. al published in the JAMA Network Open.
Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751